The possibility of objectifying the determination of the minimum erythemic dose in the lesion in vulgar psoriasis

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: Currently, the starting dose for phototherapy of various dermatoses is determined depending on the minimum erythemal dose. Minimum erythemal dose is determined subjectively by a doctor's visual assessment of the severity of erythema after preliminary irradiation with ultraviolet radiation in various doses, taking into account the Fitzpatrick skin phototype (I–VI). This method does not allow for an objective assessment of the starting dose. The use of non-invasive optical diagnostics of the skin allows obtaining data on pathological and physiological processes both in healthy skin and in pathologically altered tissues, allowing for an objective assessment of minimum erythemal dose in areas of healthy skin and its equivalent within the lesion.

AIM: To determine the differences in the optical characteristics of the skin, established using non-invasive optical diagnostic methods in the lesions of vulgar psoriasis and in the contralateral intact areas of the skin.

MATERIALS AND METHODS: A prospective, observational study involving 12 volunteers (4 women and 8 men) with psoriasis, who underwent an assessment of the optical properties of a "psoriatic plaque" in comparison with a contralateral area of healthy skin, using optical diagnostic methods (absorption spectroscopy, optical coherence tomography and diffuse reflectance spectroscopy).

RESULTS: Statistically significant differences between intact and affected skin were demonstrated by the diffuse reflection spectroscopic method. Differences in the determination of the melanin index and volumetric blood filling were also revealed. Data were obtained indicating that the melanin index can be considered as a more accurate criterion for the sensitivity of a psoriasis lesion to UFO compared to the skin phototype. The thickness of the plaque epidermis and the volume of blood filling of the tissues within it were higher than in areas of intact skin of the contralateral localization.

CONCLUSION: Based on the results of the study, we assume that the minimum erythemal dose in the area of the unaffected skin and in the lesion in vulgar psoriasis will differ and the minimum erythemal dose value in the lesion can be predicted non-invasively and safely using optical diagnostic methods.

全文:

受限制的访问

作者简介

Elizaveta Abalukhova

Moscow Regional Research and Clinical Institute

编辑信件的主要联系方式.
Email: ladybird2016@gmail.com
ORCID iD: 0009-0003-5831-4977
SPIN 代码: 2642-7960
俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

Maria Shtyfluk

Moscow Regional Research and Clinical Institute

Email: smel12.work@gmail.com
ORCID iD: 0009-0002-9422-9289
SPIN 代码: 2622-3922
俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

Anton Molochkov

Moscow Regional Research and Clinical Institute

Email: antmd@yandex.ru
ORCID iD: 0000-0002-6456-998X
SPIN 代码: 8853-5050

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

Dmitry Rogatkin

Moscow Regional Research and Clinical Institute

Email: rogatkin@medyphyslab.com
ORCID iD: 0000-0002-7755-308X
SPIN 代码: 9130-8111

Dr. Sci. (Engineering), Assistant Professor

俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

Maria Monaenkova

Moscow Regional Research and Clinical Institute

Email: mar.monaenkova@gmail.com
ORCID iD: 0000-0001-8479-1978
SPIN 代码: 9662-8661
俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

Albina Khlebnikova

Moscow Regional Research and Clinical Institute

Email: alb9696@yandex.ru
ORCID iD: 0000-0003-4400-5631
SPIN 代码: 7838-2703

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

Marina Gureeva

Moscow Regional Research and Clinical Institute

Email: Marina.gureeva@mail.ru
ORCID iD: 0000-0001-8212-6210
SPIN 代码: 6226-9486

MD, Cand. Sci. (Medicine), Assistant Professor

俄罗斯联邦, 61/2 Shepkina st, Moscow, 129110

参考

  1. Volnukhin VA. Skin disease phototherapy. part i: basic aspects of application. Russian journal of Clinical dermatology and venereology. 2018;17(6):78–84. doi: 10.17116/klinderma20181706178 EDN: YWWNED
  2. Van de Kerkhof PC, de Gruijl FR. Phototherapy in the perspective of the chronicity of psoriasis. J Eur Acad Dermatol Venereol. 2020;34(5):926–931. doi: 10.1111/jdv.16245
  3. Englert K, Kłosowicz A, Pelc P, et al. The impact of therapeutic modalities on patients with atopic dermatitis, psoriasis and vitiligo treated with phototherapy in the Jagiellonian University Outpatient Clinic. Pol Merkur Lekarski. 2019;46(273):125–129.
  4. Ibbotson SH, Bilsland D, Coc NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: A British Photodermatology Group Workshop Report. Br J Dermatol. 2004;151(2):283–297. doi: 10.1111/j.1365-2133.2004.06128.x
  5. Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159(4):931–935. doi: 10.1111/j.1365-2133.2008.08776.x
  6. Shtyflyuk ME, Raznitsyna IA, Rogatkin DA. The predicting the value of local individual minimal erythema dose without test ultraviolet irradiation. Medical physics. 2023;(4):61–77. doi: 10.52775/1810-200X-2023-100-4-61-77 EDN: UAFVQQ
  7. Heckman CJ, Chandler R, Kloss JD, et al. Minimal erythema dose (MED) testing. J Vis Exp. 2013;(75):e50175. doi: 10.3791/50175
  8. Makmatov-Rys MB, Rogatkin DA, Gureeva MA, et al. Modern approaches for the objective assessment of minimal erythema dose. Medical physics. 2021;(3):82–101 doi: 10.52775/1810-200X-2021-91-3-82-101 EDN: SBWKOX
  9. Gureeva MA. Ob»ektivizatsiya opredeleniya minimal’noi eritemnoi dozy s ispol’zovaniem metodov neinvazivnoi opticheskoi diagnostiki dlya provedeniya fototerapii dermatozov [dissertation abstract]. Moscow; 2023. 18 р. (In Russ.)
  10. Welti M, Ramelyte E, Dummer R, Imhof L. Evaluation of the minimal erythema dose for UVB and UVA in context of skin phototype and nature of photodermatosis. Photodermatol Photoimmunol Photomed. 2020;36(3):200–207. doi: 10.1111/phpp.12537
  11. Raznitsyna IA, Tarasov AP, Rogatkin DA. An improved system for in vivo fluorescent analysis in medicine. Instruments and Experimental Techniques. 2020;63(2):267−272. doi: 10.31857/S0032816220020068 EDN: DAQLMP
  12. Shtyflyuk ME, Raznitsyna IA, Glazkova PA, et al. Formulating the problem of determination of individual local minimal erythema dose without test exposures. In: Conference: 2023 Radiation and Scattering of Electromagnetic Waves (RSEMW), Divnomorskoe, Krasnodar Region, June 2023. Divnomorskoe; 2023. P. 352–355. doi: 10.1109/RSEMW58451.2023.10202086
  13. Hong Y, Song B, Chen HD, Gao XH. Melanocytes and skin immunity. J Investig Dermatol Symp Proc. 2015;17(1):37–39. doi: 10.1038/jidsymp.2015.14
  14. Speight EL, Farr PM. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA. Br J Dermatol. 1994;131(5):667–672. doi: 10.1111/j.1365-2133.1994.tb04980.x

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. Comparison of the magnitude of the detected signal of backscattered radiation of 310, 320 and 337 nm from intact skin and psoriatic plaque. (The authors’ own research). Source: Abalukhova ED et al., 2025.

下载 (653KB)
3. Fig. 2. Comparison of the melanin index of intact skin and psoriatic plaque. (The authors’ own research). Source: Abalukhova ED et al., 2025.

下载 (224KB)
4. Fig. 3. Comparison of the relative index of volumetric blood filling of intact skin and plaque. (The authors’ own research). Source: Abalukhova ED et al., 2025.

下载 (216KB)
5. Fig. 4. Optical coherence tomography: transverse sections indicating the boundaries of the 5 optical layers of intact skin and psoriatic plaque of one of the patients (a). Angio-scans of intact skin and plaques at a depth d corresponding to the average thickness of the epidermis of this patient (b, c). (The authors’ own research). Source: Abalukhova ED et al., 2025.

下载 (901KB)
6. Fig. 5. Comparison of the average thickness of the epidermis of intact skin and plaque. (The authors’ own research). Source: Abalukhova ED et al., 2025.

下载 (234KB)

版权所有 © Eco-Vector, 2025



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.